A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome

Chemistry - A European Journal

Volumn 22, Issue 5, 2016, Pages 1714-1721

  Richichi, B ^a   Baldoneschi, V ^a   Burgalassi, S ^b   Fragai, M ^a   Vullo, D ^a   Akdemir, A ^c   Dragoni, E ^a   Louka, A ^a   Mamusa, M ^a   Monti, D ^b   Berti, D ^a   Novellino, E ^d   Rosa, G De ^d   Supuran, C T ^a   Nativi, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

dendrimers; drug delivery; drug discovery; inhibitors; metalloproteins

Indexed keywords

CARBONIC ANHYDRASE; CORROSION INHIBITORS; DENDRIMERS; DRUG DELIVERY; PROTEINS; SULFUR COMPOUNDS;

CATALYTIC DOMAINS; DRUG DISCOVERY; EFFICIENT DRUG DELIVERY; HUMAN CARBONIC ANHYDRASES; MATRIX METALLOPROTEINASES; METALLO-PROTEINS; NANOMOLAR INHIBITORS; SULFONAMIDE DERIVATIVES;

ENZYME INHIBITION;

CARBONATE DEHYDRATASE INHIBITOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRY EYE SYNDROMES; HUMAN; METABOLISM;

ANIMALS; CARBONIC ANHYDRASE INHIBITORS; DRUG DELIVERY SYSTEMS; DRY EYE SYNDROMES; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES;

EID: 84958051260     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201504355     Document Type: Article

References (34)

1. J. Cathcart, A. Pulkoski-Gross, J. Cao, Gene Dis. 2015, 2, 26, and references cited therein.
2. J. W. Skiles, N. C. Gonnella, A. Y. Jeng, Curr. Med. Chem. 2001, 8, 425 and refs cited therein.
3. I. Bertini, V. Calderone, M. Cosenza, M. Fragai, Y.-M- Lee, C. Luchinat, S. Mangani, B. Terni, P. Turano, Proc. Natl. Acad. Sci. USA 2005, 102, 5334.
4. V. Calderone, M. Fragai, C. Luchinat, C. Nativi, B. Richichi, S. Roelens, ChemMedChem 2006, 1, 598.
5. E. Attolino, V. Calderone, E. Dragoni, M. Fragai, B. Richichi, C. Luchinat, C. Nativi, Eur. J. Med. Chem. 2010, 45, 5919.
6. C. S. De Paiva, R. M. Corrales, A. L. Villarreal, W. J. Farley, D.-Q. Li, M. E. Stern, S. C. Pflugfelder, Exp. Eye Res. 2006, 83, 526.
7. C. S. De Paiva, S. Chotikavanich, S. B. Pangelinan, J. D. Pitcher 3rd, B. Fang, X. Zheng, P. Ma, W. J. Farley, K. F. Siemasko, J. Y. Niederkon, M. E. Stern, D. Q. Li, S. C. Plugfelder, Mucosal Immunol. 2009, 2, 243.
8. P. Aragona, M. A. Aguennouz, L. Rania, E. Postorino, M. S. Sommario, A. M. Roszkowska, M. G. De Pasquale, A. Pisani, D. Puzzolo, Ophtalmology 2015, 122, 62.
9. J. G. Souza, K. Dias, T. Aparecida Pereira, D. Spuri Bernardi, R. F. V. Lopez, J. Pharm. Pharmacol. 2014, 66, 507.
10. M. Mori, E. De Lorenzo, E. Torre, M. Fragai, C. Nativi, C. Luchinat, A. Arcangeli, Basic Clin. Pharmacol. Toxicol. 2012, 111, 289.
11. J. Vandervoort, A. Ludwig, Nanomedicine 2007, 2, 11.
12. S. K. Sahoo, F. Dilnawaz, S. Krishnakumar, Drug Discovery Today 2008, 13, 144.
13. E. Abbasi, S. F. Aval, A. Akbarzadeh, M. Milani, H. T. Nasrabadi, S. W. Joo, Y. Hanifehpour, K. Nejati-Koshki, R. Pashaei-Asl, Nanoscale Res. Lett. 2014, 9, 247.
14. T. F. Vandamme, L. Brobeck, J. Controlled Release 2005, 102, 23.
15. N. K. Jain, U. Gupta, Exp. Opin. Drug Metabolism Toxicol. 2008, 4, 1035.
16. I. Bertini, M. Fragai, C. Luchint, M. Melikian, E. Mylonas, N. Sarti, D. I. Svergun, J. Biol. Chem. 2009, 284, 12821.
17. I. Bertini, V. Calderone, M. Fragai, R. Jaiswal, C. Luchinat, M. Melikian, E. Mylonas, D. I. Svergun, J. Am. Chem. Soc. 2008, 130, 7011.
18. J. Garcia de La Torre, M. L. Huertas, B. Carrasco, J. Magn. Reson. 2000, 147, 138.
19. A. Di Fiore, A. Maresca, C. T. Supuran, G. De Simone, Chem. Commun. 2012, 48, 8838.
20. B. F. Carta, S. M. Osman, D. Vullo, A. Gullotto, J. Y. Winum, Z. AlOthman, E. Masini, C. T. Supuran, J. Med. Chem. 2015, 58, 4039.
21. C. T. Supuran, Nat. Rev. Drug Discovery 2008, 7, 168.
22. F. Fabrizi, F. Mincione, T. Somma, G. Scozzafava, F. Galassi, E. Masini, F. Impagnatiello, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2012, 27, 138.
23. F. Carta, C. T. Supuran, Expert Opin. Ther. Pat. 2013, 23, 681.
24. C. T. Supuran, Expert Opin. Ther. Pat. 2013, 23, 677.
25. A. Scozzafava, C. T. Supuran, F. Carta, Expert Opin. Ther. Pat. 2013, 23, 725.
26. E. Masini, F. Carta, A. Scozzafava, C. T. Supuran, Expert Opin. Ther. Pat. 2013, 23, 705.
27. S. D. Jaanus, J. H. Carter, in Clinical Ocular Pharmacology (Eds.:, J. D. Bartlett, S. D. Jaanus,), Butterworth-Heinemann, St. Louis (USA), 1995, pp. 167-182.
28. S. Burgalassi, L. Panichi, P. Chetoni, M. F. Saettone, E. Boldrini, Ophthalmic Res. 1999, 31, 229.
29. B. Xiao, Y. Wang, P. S. Reinach, Y. Ren, J. Li, S. Hua, H. Lu, W. Chen, PLoS ONE 10(1): e0115333 DOI: 10.1371/journal.pone.0115333.
30. R. G. Khalifah, J. Biol. Chem. 1971, 246, 2561.
31. A. Maresca, C. Temperini, H. Vu, N. B. Pham, S. A. Poulsen, A. Scozzafava, R. J. Quinn, C. T. Supuran, J. Am. Chem. Soc. 2009, 131, 3057.
32. A. Maresca, C. Temperini, L. Pochet, B. Masereel, A. Scozzafava, C. T. Supuran, J. Med. Chem. 2010, 53, 335.
33. J.-Y. Winum, A. Maresca, F. Carta, A. Scozzafava, C. T. Supuran, Chem. Commun. 2012, 48, 8177.
34. O. Schirmer, Arch. Klin. Ophthalmol 1903, 56, 197.